Follow the people · Insider
Garo H. Armen
Garo H. Armen files insider transactions with the SEC as an exec. chair & principal off of Protagenic Therapeutics, Inc.\new (PTIX). We hold 7 disclosed purchases and sales filed since 23 February 2006, 7 of them in the last 90 days.
- Files forPTIX
- Disclosed buys and sells7 in all, 7 in the last 90 days
- Last disclosure24 August 2026
Positions held
9 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 16 October 2017 — 21 August 2026Exec. Chair & Principal Off · Protagenic Therapeutics, Inc.\new (PTIX)11 Form 4 lines · source: SEC Form 4
- Filed 22 February 2006 — 10 August 2026Director and Officer · Antigenics Inc /de/ (AGEN)326 Form 4 lines · source: SEC Form 4
- Filed 28 December 2021 — 5 May 2023Director · MiNK Therapeutics (INKT)4 Form 4 lines · source: SEC Form 4
- Filed 26 January 2010 — 31 March 2017Chairman and CEO · Antigenics Inc /de/ (agen)18 Form 4 lines · source: SEC Form 4
- Filed 17 June 2016 — 17 June 2016Director and Officer and 10% owner · Protagenic Therapeutics, Inc. ew (ATRN)1 Form 4 line · source: SEC Form 4
- Filed 17 June 2016 — 17 June 2016Director and Officer and 10% owner · Protagenic Therapeutics, Inc. ew (ATRND)1 Form 4 line · source: SEC Form 4
- Filed 30 September 2011 — 3 October 2011Chairman & CEO · Agenus (agend)2 Form 4 lines · source: SEC Form 4
- Filed 1 December 2010 — 1 December 2010Chairman & CEO · Antigenics Inc /de/ (Agen)1 Form 4 line · source: SEC Form 4
- Filed 24 May 2006 — 24 August 2007Director · Color Kinetics (CLRK)17 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 20,000 shares of Protagenic Therapeutics, Inc.\newSEC Form 424 August 2026COMMON STOCK · traded 21 August 2026 · filed 24 August 2026
- ▲ bought on the open market 2,700 shares of Protagenic Therapeutics, Inc.\newSEC Form 420 August 2026COMMON STOCK · traded 19 August 2026 · filed 20 August 2026
- ▲ bought on the open market 16,634 shares of Protagenic Therapeutics, Inc.\newSEC Form 420 August 2026COMMON STOCK · traded 20 August 2026 · filed 20 August 2026
- was granted 1,971,500 shares of Agenus (a derivative holding)SEC Form 412 August 2026Stock Option · traded 10 August 2026 · filed 12 August 2026
- ▲ bought on the open market 2,220 shares of Protagenic Therapeutics, Inc.\newSEC Form 412 August 2026COMMON STOCK · traded 11 August 2026 · filed 12 August 2026
- ▲ bought on the open market 685 shares of Protagenic Therapeutics, Inc.\newSEC Form 410 August 2026COMMON STOCK · traded 6 August 2026 · filed 10 August 2026
- ▲ bought on the open market 5,000 shares of Protagenic Therapeutics, Inc.\newSEC Form 46 August 2026COMMON STOCK · traded 5 August 2026 · filed 6 August 2026
- ▲ bought on the open market 26,291 shares of Protagenic Therapeutics, Inc.\newSEC Form 43 August 2026COMMON STOCK · traded 30 July 2026 · filed 3 August 2026
- was granted 4,852 shares of AgenusSEC Form 414 July 2026Common Stock · traded 10 July 2026 · filed 14 July 2026
- was granted 5,364 shares of AgenusSEC Form 430 June 2026Common Stock · traded 26 June 2026 · filed 30 June 2026
- was granted 4,925 shares of AgenusSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- was granted 4,644 shares of AgenusSEC Form 42 June 2026Common Stock · traded 29 May 2026 · filed 2 June 2026
- was granted 4,540 shares of AgenusSEC Form 419 May 2026Common Stock · traded 15 May 2026 · filed 19 May 2026
- was granted 4,233 shares of AgenusSEC Form 45 May 2026Common Stock · traded 1 May 2026 · filed 5 May 2026
- was granted 1,000,000 shares of Agenus (a derivative holding)SEC Form 428 April 2026Stock Option · traded 24 April 2026 · filed 28 April 2026
- was granted 27,750 shares of Agenus (a derivative holding)SEC Form 428 April 2026Stock Option · traded 24 April 2026 · filed 28 April 2026
- was granted 137,550 shares of Agenus (a derivative holding)SEC Form 428 April 2026Stock Option · traded 24 April 2026 · filed 28 April 2026
- was granted 3,403 shares of AgenusSEC Form 421 April 2026Common Stock · traded 17 April 2026 · filed 21 April 2026
- was granted 4,629 shares of AgenusSEC Form 46 April 2026Common Stock · traded 3 April 2026 · filed 6 April 2026
- was granted 3,983 shares of AgenusSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- was granted 3,983 shares of AgenusSEC Form 424 March 2026Common Stock · traded 20 March 2026 · filed 24 March 2026
- was granted 4,994 shares of AgenusSEC Form 49 March 2026Common Stock · traded 6 March 2026 · filed 9 March 2026
- was granted 4,994 shares of AgenusSEC Form 49 March 2026Common Stock · traded 6 March 2026 · filed 9 March 2026
- was granted 4,829 shares of AgenusSEC Form 424 February 2026Common Stock · traded 20 February 2026 · filed 24 February 2026
- was granted 4,829 shares of AgenusSEC Form 424 February 2026Common Stock · traded 20 February 2026 · filed 24 February 2026
- was granted 5,027 shares of AgenusSEC Form 49 February 2026Common Stock · traded 6 February 2026 · filed 9 February 2026
- was granted 5,027 shares of AgenusSEC Form 49 February 2026Common Stock · traded 6 February 2026 · filed 9 February 2026
- was granted 4,562 shares of AgenusSEC Form 426 January 2026Common Stock · traded 23 January 2026 · filed 26 January 2026
- was granted 4,562 shares of AgenusSEC Form 426 January 2026Common Stock · traded 23 January 2026 · filed 26 January 2026
- was granted 3,780 shares of AgenusSEC Form 412 January 2026Common Stock · traded 9 January 2026 · filed 12 January 2026
- was granted 3,780 shares of AgenusSEC Form 412 January 2026Common Stock · traded 9 January 2026 · filed 12 January 2026
- was granted 4,942 shares of AgenusSEC Form 429 December 2025Common Stock · traded 26 December 2025 · filed 29 December 2025
- was granted 4,316 shares of AgenusSEC Form 415 December 2025Common Stock · traded 12 December 2025 · filed 15 December 2025
- was granted 3,587 shares of AgenusSEC Form 41 December 2025Common Stock · traded 28 November 2025 · filed 1 December 2025
- was granted 3,769 shares of AgenusSEC Form 417 November 2025Common Stock · traded 14 November 2025 · filed 17 November 2025
- was granted 4,120 shares of AgenusSEC Form 45 November 2025Common Stock · traded 31 October 2025 · filed 5 November 2025
- was granted 4,216 shares of AgenusSEC Form 421 October 2025Common Stock · traded 17 October 2025 · filed 21 October 2025
- was granted 3,951 shares of AgenusSEC Form 46 October 2025Common Stock · traded 3 October 2025 · filed 6 October 2025
- was granted 3,734 shares of AgenusSEC Form 423 September 2025Common Stock · traded 19 September 2025 · filed 23 September 2025
- was granted 3,778 shares of AgenusSEC Form 49 September 2025Common Stock · traded 5 September 2025 · filed 9 September 2025
- was granted 3,619 shares of AgenusSEC Form 426 August 2025Common Stock · traded 22 August 2025 · filed 26 August 2025
- was granted 3,407 shares of AgenusSEC Form 411 August 2025Common Stock · traded 8 August 2025 · filed 11 August 2025
- was granted 2,745 shares of AgenusSEC Form 428 July 2025Common Stock · traded 25 July 2025 · filed 28 July 2025
- was granted 2,317 shares of AgenusSEC Form 415 July 2025Common Stock · traded 11 July 2025 · filed 15 July 2025
- was granted 61,397 shares of AgenusSEC Form 430 June 2025Common Stock · traded 18 June 2025 · filed 30 June 2025
- was granted 3,436 shares of AgenusSEC Form 430 June 2025Common Stock · traded 27 June 2025 · filed 30 June 2025
- was granted 37,500 shares of Agenus (a derivative holding)SEC Form 420 June 2025Stock Option · traded 17 June 2025 · filed 20 June 2025
- was granted 3,480 shares of AgenusSEC Form 417 June 2025Common Stock · traded 13 June 2025 · filed 17 June 2025
- was granted 4,769 shares of AgenusSEC Form 43 June 2025Common Stock · traded 30 May 2025 · filed 3 June 2025
- was granted 4,700 shares of AgenusSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- was granted 5,260 shares of AgenusSEC Form 45 May 2025Common Stock · traded 2 May 2025 · filed 5 May 2025
- was granted 7,886 shares of AgenusSEC Form 422 April 2025Common Stock · traded 18 April 2025 · filed 22 April 2025
- was granted 10,288 shares of AgenusSEC Form 48 April 2025Common Stock · traded 4 April 2025 · filed 8 April 2025
- was granted 9,243 shares of AgenusSEC Form 424 March 2025Common Stock · traded 21 March 2025 · filed 24 March 2025
- was granted 6,332 shares of AgenusSEC Form 411 March 2025Common Stock · traded 7 March 2025 · filed 11 March 2025
- was granted 4,483 shares of AgenusSEC Form 425 February 2025Common Stock · traded 21 February 2025 · filed 25 February 2025
- was granted 4,251 shares of AgenusSEC Form 411 February 2025Common Stock · traded 7 February 2025 · filed 11 February 2025
- was granted 4,169 shares of AgenusSEC Form 428 January 2025Common Stock · traded 24 January 2025 · filed 28 January 2025
- was granted 4,777 shares of AgenusSEC Form 413 January 2025Common Stock · traded 10 January 2025 · filed 13 January 2025
- was granted 5,931 shares of AgenusSEC Form 430 December 2024Common Stock · traded 27 December 2024 · filed 30 December 2024
- was granted 5,347 shares of AgenusSEC Form 416 December 2024Common Stock · traded 13 December 2024 · filed 16 December 2024
- was granted 4,769 shares of AgenusSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- was granted 600,000 shares of Agenus (a derivative holding)SEC Form 418 November 2024Stock Option · traded 14 November 2024 · filed 18 November 2024
- was granted 5,997 shares of AgenusSEC Form 418 November 2024Common Stock · traded 15 November 2024 · filed 18 November 2024
- was granted 4,207 shares of AgenusSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- was granted 3,530 shares of AgenusSEC Form 421 October 2024Common Stock · traded 18 October 2024 · filed 21 October 2024
- was granted 3,349 shares of AgenusSEC Form 47 October 2024Common Stock · traded 4 October 2024 · filed 7 October 2024
- was granted 2,793 shares of AgenusSEC Form 424 September 2024Common Stock · traded 20 September 2024 · filed 24 September 2024
- was granted 3,295 shares of AgenusSEC Form 49 September 2024Common Stock · traded 6 September 2024 · filed 9 September 2024
- was granted 2,982 shares of AgenusSEC Form 427 August 2024Common Stock · traded 23 August 2024 · filed 27 August 2024
- was granted 3,204 shares of AgenusSEC Form 412 August 2024Common Stock · traded 9 August 2024 · filed 12 August 2024
- was granted 2,486 shares of AgenusSEC Form 429 July 2024Common Stock · traded 26 July 2024 · filed 29 July 2024
- was granted 1,046 shares of AgenusSEC Form 415 July 2024Common Stock · traded 12 July 2024 · filed 15 July 2024
- was granted 973 shares of AgenusSEC Form 41 July 2024Common Stock · traded 28 June 2024 · filed 1 July 2024
- was granted 65,651 shares of Agenus (a derivative holding)SEC Form 418 June 2024Stock Option · traded 11 June 2024 · filed 18 June 2024
- was granted 108,000 shares of Agenus (a derivative holding)SEC Form 418 June 2024Stock Option · traded 11 June 2024 · filed 18 June 2024
- was granted 1,055 shares of AgenusSEC Form 418 June 2024Common Stock · traded 14 June 2024 · filed 18 June 2024
- was granted 1,040 shares of AgenusSEC Form 43 June 2024Common Stock · traded 31 May 2024 · filed 3 June 2024
- was granted 1,502 shares of AgenusSEC Form 420 May 2024Common Stock · traded 17 May 2024 · filed 20 May 2024
- was granted 1,248 shares of AgenusSEC Form 47 May 2024Common Stock · traded 3 May 2024 · filed 7 May 2024
- was granted 3,080 shares of AgenusSEC Form 422 April 2024Common Stock · traded 19 April 2024 · filed 22 April 2024
- was granted 32,697 shares of AgenusSEC Form 48 April 2024Common Stock · traded 5 April 2024 · filed 8 April 2024
- was granted 250,000 shares of Protagenic Therapeutics, Inc. ew (a derivative holding)SEC Form 429 March 2024PTIX Common stock Options · traded 25 March 2024 · filed 29 March 2024
- was granted 27,163 shares of AgenusSEC Form 425 March 2024Common Stock · traded 22 March 2024 · filed 25 March 2024
- was granted 22,136 shares of AgenusSEC Form 411 March 2024Common Stock · traded 8 March 2024 · filed 11 March 2024
- was granted 21,815 shares of AgenusSEC Form 427 February 2024Common Stock · traded 23 February 2024 · filed 27 February 2024
- ▲ bought on the open market 500,000 shares of AgenusSEC Form 415 February 2024Common Stock · traded 15 February 2024 · filed 15 February 2024
- was granted 19,778 shares of AgenusSEC Form 412 February 2024Common Stock · traded 9 February 2024 · filed 12 February 2024
- was granted 22,475 shares of AgenusSEC Form 429 January 2024Common Stock · traded 26 January 2024 · filed 29 January 2024
- was granted 23,177 shares of AgenusSEC Form 416 January 2024Common Stock · traded 12 January 2024 · filed 16 January 2024
- was granted 23,453 shares of AgenusSEC Form 43 January 2024Common Stock · traded 29 December 2023 · filed 3 January 2024
- was granted 23,453 shares of AgenusSEC Form 418 December 2023Common Stock · traded 15 December 2023 · filed 18 December 2023
- was granted 20,727 shares of AgenusSEC Form 44 December 2023Common Stock · traded 1 December 2023 · filed 4 December 2023
- was granted 23,511 shares of AgenusSEC Form 420 November 2023Common Stock · traded 17 November 2023 · filed 20 November 2023
- was granted 19,200 shares of AgenusSEC Form 46 November 2023Common Stock · traded 3 November 2023 · filed 6 November 2023
- was granted 18,142 shares of AgenusSEC Form 423 October 2023Common Stock · traded 20 October 2023 · filed 23 October 2023
- was granted 15,305 shares of AgenusSEC Form 410 October 2023Common Stock · traded 6 October 2023 · filed 10 October 2023
- was granted 13,888 shares of AgenusSEC Form 425 September 2023Common Stock · traded 22 September 2023 · filed 25 September 2023
- was granted 13,145 shares of AgenusSEC Form 411 September 2023Common Stock · traded 8 September 2023 · filed 11 September 2023
- ▼ sold on the open market 100,000 shares of MiNK TherapeuticsSEC Form 45 May 2023Common Stock · traded 5 May 2023 · filed 5 May 2023
- ▲ bought on the open market 100,000 shares of MiNK TherapeuticsSEC Form 44 May 2023Common Stock · traded 2 May 2023 · filed 4 May 2023
- was granted 200,000 shares of MiNK Therapeutics (a derivative holding)SEC Form 418 January 2023Stock Option · traded 16 January 2023 · filed 18 January 2023
- was granted 2,400,000 shares of Agenus (a derivative holding)SEC Form 49 January 2023Stock Option · traded 5 January 2023 · filed 9 January 2023
- was granted 241,383 shares of AgenusSEC Form 49 January 2023Common Stock · traded 5 January 2023 · filed 9 January 2023
- gave away 360,000 shares of MiNK TherapeuticsSEC Form 414 February 2022Common Stock · traded 28 December 2021 · filed 14 February 2022
- was granted 237,011 shares of AgenusSEC Form 44 February 2022Common Stock · traded 2 February 2022 · filed 4 February 2022
- was granted 1,900,000 shares of Agenus (a derivative holding)SEC Form 44 January 2022Stock Option (Right to Buy) · traded 2 January 2022 · filed 4 January 2022
- exercised options over 119,178 shares of Agenus (a derivative holding)SEC Form 414 September 2021Stock Option, right to buy · traded 13 September 2021 · filed 14 September 2021
- exercised options over 119,178 shares of AgenusSEC Form 414 September 2021Common Stock · traded 13 September 2021 · filed 14 September 2021
- ▼ sold on the open market 82,107 shares of AgenusSEC Form 414 September 2021Common Stock · traded 13 September 2021 · filed 14 September 2021
- was granted 1,900,000 shares of Agenus (a derivative holding)SEC Form 42 July 2021Stock Option · traded 15 June 2021 · filed 2 July 2021
- was granted 2,679 shares of AgenusSEC Form 42 July 2021Common Stock · traded 2 July 2021 · filed 2 July 2021
- was granted 2,812 shares of AgenusSEC Form 421 June 2021Common Stock · traded 18 June 2021 · filed 21 June 2021
- was granted 3,670 shares of AgenusSEC Form 47 June 2021Common Stock · traded 4 June 2021 · filed 7 June 2021
- was granted 3,530 shares of AgenusSEC Form 421 May 2021Common Stock · traded 21 May 2021 · filed 21 May 2021
- was granted 4,817 shares of AgenusSEC Form 47 May 2021Common Stock · traded 7 May 2021 · filed 7 May 2021
- was granted 4,849 shares of AgenusSEC Form 423 April 2021Common Stock · traded 23 April 2021 · filed 23 April 2021
- was granted 4,645 shares of AgenusSEC Form 49 April 2021Common Stock · traded 9 April 2021 · filed 9 April 2021
- was granted 135,778 shares of AgenusSEC Form 45 April 2021Common Stock · traded 2 April 2021 · filed 5 April 2021
- was granted 4,177 shares of AgenusSEC Form 429 March 2021Common Stock · traded 26 March 2021 · filed 29 March 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.